Physician profile
Keith Eric Brightbill
NPI 1104049980
$12,245.35
in general payments reported to CMS, 2019-2025
53 companies · $1,295 in 2025
The $1,295 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,403 · 2020: $1,146 · 2021: $1,003 · 2022: $2,653 · 2023: $1,969 · 2024: $1,777 · 2025: $1,295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,040.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,040.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $1,609.64 | 2019-2020 | |
| Coloplast Corp | $1,453.15 | 2019-2025 | Speedicath, Titan, Porges Coloplast |
| Teleflex LLC | $1,298.87 | 2021-2025 | Urolift |
| Medtronic, INC. | $919.54 | 2021-2025 | Interstim |
| Astellas Pharma US INC | $778.53 | 2019-2025 | Myrbetriq, Xtandi |
| Abbvie INC. | $640.50 | 2019-2025 | Botox |
| Janssen Biotech, INC. | $624.30 | 2019-2025 | Erleada, Akeega |
| Accord Healthcare, INC. | $469.60 | 2022-2025 | |
| Antares Pharma, INC. | $459.61 | 2020-2025 | Xyosted, Nocdurna, Tlando |
| Pfizer INC. | $359.56 | 2019-2025 | |
| Urogen Pharma, INC. | $327.35 | 2021-2025 | Jelmyto |
| Allergan, INC. | $312.39 | 2019-2022 | |
| Myriad Genetic Laboratories, INC. | $269.82 | 2020-2024 | Prolaris |
| Olympus America INC. | $248.48 | 2022-2025 | Itind System |
| Ferring Pharmaceuticals INC. | $229.97 | 2019-2025 | Adstiladrin |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Brightbill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.